GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of how much of what we believe about API source actually comes from telehealth threads — 35 comments in the full submission. View in context.
3.8k
c/compounding·submitted 1 year ago by u/elin_ferrari

how much of what we believe about API source actually comes from telehealth threads

PSAbranch of 7 comments

how much of what we believe about API source actually comes from telehealth threads. I am not trying to be the "source?" guy. I would just like a source. Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot. Asked for the beyond-use date basis and…

Read the full submission and all 35 comments →

This branch

7 comments, started 1 year ago
u/kian_ferreira65 points·1 year ago

What concentration is on the label, and does it match what you were expecting?

replysharereportpermalink
[deleted]44 points·1 year ago

[deleted]

replysharereportpermalink
u/ignacio_vanhecke29 points·1 year ago

Agreed on potency testing of the finished preparation. That is a different question from the purity of the starting material.

replysharereportpermalink
u/elin_ferrariOP0 points·1 year ago

Was there potency testing on the finished preparation, or only on the starting material?

replysharereportpermalink
u/discount_math_dm1 point·1 year ago

Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.

replysharereportpermalink
u/amara_kuipers1 point·1 year ago

a telehealth intake that asks nothing has told you what it is

replysharereportpermalink
u/hydration_hank0 points·1 year ago

What is the beyond-use date and what is it based on?

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →